About this trial
Research indicates that individuals diagnosed with lung or esophageal cancer who enter treatment with higher functional capacities, improved body composition, and better nutrition status tend to experience better outcomes and a higher quality of life. The primary objective of a prehabilitation health coaching program is to enhance the overall health and well-being of patients before they undergo major surgery.This personalized 8-week program encompasses elements such as nutrition, smoking cessation, sleep hygiene, and movement, equipping participants with the knowledge and tools needed to adopt healthier lifestyles.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with lung or esophageal cancer
Scheduled to receive surgical intervention in minimum 2-weeks
Surgeon approval
Able to read and write in English
Disqualifiers
Not able to provide informed consent
Trial design
Parallel
Treatments tested in this trial
Prehabilitation
Behavioral8-week community based prehab program
Treatment groups
Trial outcomes
Primary outcomes
Feasibility- Recruitment
Participant accrual as defined as the number of eligible participants who consent to participate
Feasibility- Participant fidelity
Participant adherence to prescribed exercise intervention
Feasibility - Safety
Adverse and serious adverse events
Feasibility - Retention/Attrition
Percentage of participants who complete the 12-week intervention
Secondary outcomes
Functional Assessment of Cancer Therapy - Lung OR Esophageal (FACT-L/ FACT- E)
44 item that measures multidimensional quality of life
Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F)
a 13-item questionnaire that evaluates an individual's self-reported fatigue during their usual daily activities over the past week
5x chair stand
To test functional strengths, risk of falling and overall leg strength and endurance
Stair climb test
To test functional strength, balance and agility
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Nova Scotia Health Authority
Lead sponsor
Dalhousie University
Collaborator